Bonjour à tous.
Un article qui semble intéressant dans le South China Morning Post de ce matin :
Après, je n'ai aucune idée de la valeur de l'étude, mais j'ai été interpelé par le caractère d'urgence de la demande d'autorisation pour essais cliniques.A drug used to treat an infectious disease in cats effectively stopped the replication of the pandemic coronavirus
in laboratory tests, according to Chinese researchers.
The findings come just weeks after the American developer of the feline medicine announced that it had applied to the US Food and Drug Administration for emergency approval to start clinical trials of the drug on humans.
In a non-peer-review paper posted on the preprint server bioRxiv on Sunday, researchers led by Professor Zhang Shuyang at the Chinese Academy of Medical Sciences said that computer modelling and laboratory experiments suggested that the medication called GC376 was “a relatively effective and safe drug candidate”.
The drug binds to an important enzyme of Sars-CoV-2, the coronavirus that causes the disease Covid-19, according to the study. The enzyme, called Mpro, breaks down big proteins into amino acids and the virus uses these amino acids as building blocks. Without Mpro, the virus cannot make copies of itself.
-----